ERShares Private-Public Crossover ETF (XOVR)

As a hedge fund PM watching the XOVR situation unfold, the mechanics are fascinating yet alarming. When investors pulled about $630 million out in late February 2026, the fund had to sell its public stock to meet redemptions. That caused its illiquid SpaceX stake to balloon to over 44% of net assets. That’s nearly triple the SEC's 15% limit for illiquid holdings. It highlights a massive structural flaw in trying to wrap private equity into a daily-traded wrapper.

On our desk, we are looking closely at ERShares' decision to halt new creation unit issuance and levy a redemption fee of up to 2% right before the SpaceX IPO on June 12, 2026. While CEO Joel Shulman claims they are shunning 'hot money,' the reality is they were cornered by a liquidity crunch of their own making. This completely disrupts standard ETF arbitrage mechanisms.

From a risk manager's perspective, the due diligence failure here is striking. Morningstar and other analysts pointed out that XOVR has performed poorly—losing 4.6% annually since December 2024—while public holdings lagged even as broad US indexes rose. Relying on specialized special-purpose vehicles for private stakes while managing daily liquidity was an accident waiting to happen.

Watching the 50-day moving averages and fund flows on our terminal, the takeaway is clear: XOVR serves as a cautionary tale for the entire ETF industry. As more firms attempt to roll out crossover products to retail investors, regulators will undoubtedly scrutinize how funds handle illiquid assets during periods of stress and heavy redemptions.

Looking at market sentiment from retail and institutional circles, the narrative around XOVR being a pioneer in crossover investing has soured. Eva Ados and Brad Roth tried to market the fund as a category leader leveraging the Entrepreneur Factor framework, but the reality on the ground is that investors got trapped in an asset concentration nightmare as SpaceX's valuation hit $1 trillion.